Position in ZVRA
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,485,822
New position
Shares Held
159,423
first reported quarter
Ownership
0.270%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 16.838222841120793.ToString("F0")%
Shared 0.ToString("F0")%
None 83.16177715887922.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Phocas Financial Corp. holds $6,718,190 across 5 Biotechnology names. ZVRA ranks #2 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACAD |
Acadia Pharmaceuticals Inc
|
81,347 | $1,810,784 | |
| 2 | ZVRA |
Zevra Therapeutics, Inc.
This page
|
159,423 | $1,485,822 | |
| 3 | PTCT |
Ptc Therapeutics, Inc.
|
19,875 | $1,354,083 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
50,299 | $1,185,044 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
97,942 | $882,457 |
All Filings in ZVRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,485,822 | 159,423 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||